The tumor growth induced by subcutaneously injected MB49 cells, a syngeneic urothelial carcinoma cell line, was also dramatically blocked by the administration of anti-CD29, as previously observed in B16 melanoma-treated animals (Figures 4D–F). Here, ITGB1 is linked to urothelial carcinoma.